Search research articles
Contact Us
Filters
Showing results (91-100 of 452) with videos related to
Page
of 46
Sort By:
World Review of Nutrition and Dietetics
|
January 1, 1994
Unsaturated lipids: a new approach to the treatment of cancer
D F Horrobin
Medical Hypotheses
|
May 1, 1980
The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1
D F Horrobin
Journal of the American Academy of Dermatology
|
June 1, 1989
Essential fatty acids in clinical dermatology
D F Horrobin
Wiener Klinische Wochenschrift
|
July 15, 1988
Prostaglandin E1: physiological significance and clinical use
D F Horrobin
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
October 1, 1991
Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation
D F Horrobin
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1996
Schizophrenia as a membrane lipid disorder which is expressed throughout the body
D F Horrobin
Journal of the Royal Society of Medicine
|
March 1, 1981
What should be done about schizophrenia?
D F Horrobin
Schizophrenia Research
|
May 20, 1998
The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
D F Horrobin
Schizophrenia Bulletin
|
January 1, 1978
Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant
D F Horrobin
Lancet (London, England)
|
July 24, 1976
Bone resorption by breast-cancer tissue
D F Horrobin
Page
of 46
Search research articles
Search
Showing results (91-100 of 452) with videos related to
Sort By:
Page
of 46
World Review of Nutrition and Dietetics
|
January 1, 1994
Unsaturated lipids: a new approach to the treatment of cancer
D F Horrobin
Medical Hypotheses
|
May 1, 1980
The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1
D F Horrobin
Journal of the American Academy of Dermatology
|
June 1, 1989
Essential fatty acids in clinical dermatology
D F Horrobin
Wiener Klinische Wochenschrift
|
July 15, 1988
Prostaglandin E1: physiological significance and clinical use
D F Horrobin
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
October 1, 1991
Interactions between n-3 and n-6 essential fatty acids (EFAs) in the regulation of cardiovascular disorders and inflammation
D F Horrobin
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
August 1, 1996
Schizophrenia as a membrane lipid disorder which is expressed throughout the body
D F Horrobin
Journal of the Royal Society of Medicine
|
March 1, 1981
What should be done about schizophrenia?
D F Horrobin
Schizophrenia Research
|
May 20, 1998
The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
D F Horrobin
Schizophrenia Bulletin
|
January 1, 1978
Dopamine supersensitivity, endorphin excess, and prostaglandin E1 deficiency: three aspects of the same schizophrenic elephant
D F Horrobin
Lancet (London, England)
|
July 24, 1976
Bone resorption by breast-cancer tissue
D F Horrobin
Page
of 46